Cytotoxic intraepithelial lymphocytes in colorectal polyps and carcinomas

Anticancer Research

Volumn 19, Issue 4 B, 1999, Pages 3221-3227

  Rubio, Carlos A ^a   Jacobsson, Björn ^a   Castaños Velez, Esmeralda ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Colonic neoplasias; Intraepithelial lymphocytes

Indexed keywords

CD3 ANTIGEN; CELL ANTIGEN; FAS ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ARTICLE; COLON POLYP; COLORECTAL CARCINOMA; CYTOTOXIC LYMPHOCYTE; HUMAN; HUMAN TISSUE; INTESTINE METAPLASIA; INTESTINE MUCOSA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RECTUM POLYP; T LYMPHOCYTE; VILLOUS ADENOMA;

COLON; COLORECTAL NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; INTESTINAL POLYPS; LYMPHOCYTES, TUMOR-INFILTRATING; NEOPLASM INVASIVENESS; PHENOTYPE; RECTUM;

EID: 0033452594     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Mac Carty WG Principles of prognosis in cancer. JAMA 96: 30-33, 1931.
2. Jass JR: Lymphocytic infiltration and survival in rectal cancer J Clin Pathol 39: 585-589, 1986.
3. Coca S, Perez-Piqueras J, Martinez D, Colmenajero A, Saez MA, Vallejo C, Martos JA, Moreno M: The prognostic significance of intratumoral natural killer cells in patients with colorectal carcinoma. Cancer 79: 2320-2328, 1997.
4. Kock B, Griedl J, Hermanek P, Kalden JR: The analysis of mononuclear cell infiltration in colorectal carcinomas. J Cancer Res Clin Oncol 109: 142-151, 1985.
5. Janeway CA, Bottomly K: Signals and signs for lymphocyte responses. Cell 76: 275-285, 1994.
6. Beverly P: Tumor immunology. In: Immunology (Ed I Roitt, J Brostoff, D Male). Mosby. London 4th Edition pp 20.1-20.11, 1996.
7. Rubio CA: Intraepithelial lymphocytes versus colorectal neoplastic cells: Who is winning the apoptotic battle? a Minireview. Apoptosis 2: 489-493, 1997.
8. Rubio CA, Soderberg G, Einhorn N: Histological and follow-up studies in cases of microinvasive carcinoma of the uterine cervix. Acta Pat Microbiol Scand 82: 397-410, 1974.
9. Rubio CA, Kato Y, Hirota T, Muto T: Histologic classification of endoscopically removed flat colorectal polyps: a multicentric study. Jpn J Cancer Res 87: 849-855, 1996.
10. Rojbin RJ, Logtenberger LJ, Wiegman JM, van Berge Henegowen GP, Houwen RW, Koningsberger JC: Intestinal T lymphocytes. Scand J Gastroent, 30 Suppl 212: 23-33, 1995.
11. Ohtsuka K, Hasegawa K, Yamagiwa S, Sato K, Nakayama M, Watanabe H, Askura H, Abo T: Intraepithelial lymphocytes in colon have similar properties to intraepithelial lymphocytes in small intestine and hepatic Digest Dis Scie 41: 902-911, 1996.
12. Springer TA: Traffic signals for lymphocyte recirculation and leucocyte emigration: the multistep paradigm. Cell 76: 301-314, 1994.
13. von Boehmer H: Positive selection of Lymphocytes Cell 76: 219-228, 1994
14. Cepek KL, Parker CM, Madara JL, Brenner MB: J Immunol 150: 3459-3470, 1993) Integrin a4/b7 mediates adhesion of T lymphocytes to epithelial cells.
15. Bryant DA, Mintz ED, Puhr ND, Griffin PM, Petras RE: Colonic epithelial lymphocytosis associated with an epidemic of chronic diarrhea. Amer J Surg Pathol 20: 1102-1109, 1996.
16. Jawhari AJ, Talbot IC: Microscopic, lymphocytic and collagenous colitis. Histopathol 29: 101-110, 1996.
17. Geboes K: Collagenous and microscopic colitis: clinical importance. Netherl J Med 45: 47-51, 1994.
18. Rubio CA, Befritz R, Eriksson B, Christensson B, Duvander A, Larsson B: The topographic distribution of lymphocytic gastritis in gastrectomy specimens. APMIS 99: 815-819, 1991.
19. Lazenby AJ, Yardley JH, Giardello FM, Jessurum J, Bayless TM: Lymphocytic ("microscopic") colitis Hum Pathol 20: 8-28, 1989.
20. Yoo YK, Heo DS, Hata K, van Thiel DH, Whiteside TL: Tumor infiltrating lymphocytes from human colonic carcinomas. Gastroenterol 98: 259-26, 1990.
21. Balch CM, Riley LB, Bae YJ, Salmeron MA, Platsoucas CD, von Barth, RJ, Camp B, Martuscello TA, Dain BJ, Memoli VA: The cytokine microenvironment of human colonic carcinoma. Cancer 78: 1168-1178, 1996.
22. Eschenbach A, Itoh K: Patterns of human tumor-infiltrating lymphocytes in 120 human cancers. Arch Surg 125: 200-205, 1990.
23. Hoang P, Dalton HR, Jewell DP: Human colonic intra-epithelial lymphocytes are suppressor cells Clin Exper Immunol 85: 498-503, 1991.
24. Svennevig JL Lunde OC, Holter J, Bjorgsvik D: Lymphoid infiltration and prognosis in colorectal carcinoma Brit J Cancer 49: 375-377, 1984.
25. Taunk J, Roberts AI, Ebert EC: Spontaneous cytotoxicity of human intraepithelial lymphocytes against epithelial cell tumors. Gastroenterology 102: 69-75, 1992.
26. Wimmenauer S, Keller H, Rahner S, Kirste G, von Berwelt M, Meyer A, von Kleist S, Farthmann EH: Phenotypical and functional characteristics of tumor-infiltrating lymphocytes from colon carcinomas stimulated wilh rIL-2 and rIL-4 in vitro: comparisson with lymphocytes of the normal colon mucosa and of peripheral blood. Anticancer Res 14: 963-968, 1944.
27. Fisher ER, Sharkey DA: The ultrastructure of colonic polyps and cancer with special reference to the epithelial inclusion bodies of Leuchtenberger. Cancer 15: 160-170, 1962.
28. Germain RN: MHC-dependant antigen processing and peptide presentation: providing ligands for T lymphocyte activation Cell 76: 286-299, 1994.
29. Medley QG, Kedersha N, O'Brien S, Tian Q, Schlossman A, Sreuli M, Anderson P: Characterization of GPM-17, a granule membrane protein that moves to the plasma membrane of natural killer cells following target cell recognition. Proc Nat Acad Sci USA 93: 685-689, 1996.
30. Winawer SJ, Fletcher RH, Miller L, Godlee F, Stolar MH, Multow CD, Woolf SH, Woolf SH, Glick SN, Ganiats TG, Bond JH, Rosen L, Zapka JG, Olsen SJ, Giardiello FM, Sisk JE, van Antwerp R, Brown-Davies C, Marciniak DA, Mayer RJ: Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology 112: 594-642, 1997.
31. Merogi AJ, Marrogi AJ, Ramesh R, Robinsson WR, Fermin CD, Freeman SM: Tumor-host interaction: analysis of cytokines, growth factors, and tumor-infiltrating lymphocytes in ovarian carcinomas. Hum Pathol 28: 321-330, 1997.
32. Leuchtenberger C, Leuchtenberger R, Lieb E: Studies of the cytoplasmic inclusions containing desoxyribose nucleic acid (DNA) in human rectal polypoid tumors including familial hereditary type. Acta Genet 6: 241-297, 1956.
33. Leuehtenberger C: Cytoplasmic "inclusion bodies" containing desoxyribose nucleic acid (DNA) in cells of human rectal polyps Lab Invest 3: 132-142, 1954.
34. Walb D, Sandritter W: Inclusion bodies in rectal polyps Arch Pathol 78: 104-107, 1964.
35. Rubio CA, Alm T, Aly A, Poppen B: Intraepithelial bodies in colorectal adenomas: Leuchtenberger bodies revisited Dis Colon Rectum 34: 47-50, 1993.
36. Rubio CA, Kumagai J, Kanamori T, Nakamura K: Apoptosis in flat neoplasias of the colorectal mucosa. In Vivo 9: 173-176, 1995.
37. Rubio CA, Rodensjo M: Flat serrated adenomas and flat tubular adenomas of the colorectal mucosa: differences in the pattern of cell proliferation. Jpn J Cancer Res 86: 756-760, 1995.
38. Arai M, Chan SY, Bishop DK, Nebel GJ: Inhibition of the alloantibody response by CD95 ligand Nature Medicine 3: 843-848, 1947.
39. O'Connell J, O'Sullivan GC, Collins JK: The Fas counterattack: Fasmediated T cell killing by colon cancer cells expressing Fas ligand J Exp Med 184: 1075-1082, 1996.
40. Rubio CA: Tumor cells induce apoptosis in lymphocytes Nature Med 3: 253-254, 1997.
41. Griffith TS, Brunner T, Fletcher SM, Green DR, Ferguson TA: Fas-ligand apoptosis as a mechanism of immune privilege Science 270: 1189-1192, 1995.
42. Habne M, Rimoldi D, Scroter M, Romero P, Schreier M, French LE, Schneider P, Bornand T, Fontana A, Lienard D, Cerottini JC, Tschopp: Melanoma cell expression of Fas (Apo-1/CD95) ligand: implications for tumor immune escape Science 274: 1363-1366, 1996.
43. Hardwick JM, Oyler GA, Clem RJ: AARC meeting on programmed cell death. Lake George, 19-23 October 1996. Apoptosis 1: 171-174, 1996.
44. Hayashi H, Tatebe S, Osaki M, Goto A, Susuki Y, Ito H: Expression of Fas antigen and its mediation of apoptosis in human gastric cancer cell lines. Jap J Cancer Res 88: 49-55, 1997.
45. Niehans GA, Brunner T, Frizelle SP, Liston JC, Salerno CT, Knapp DJ, Green DR, Kratzke RA: Human lung carcinomas express Fas ligand Cancer Res 57: 1007-1012, 1997.
46. O'Mahony AM, O'Sullivan GC, O'Connell J, Cotter TG, Collins JK: An immune suppressive factor derived from esophageal squamous carcinoma induces apoptosis in normal and transformed cells of lymphoid lineage J Immunol 151: 4847-4856, 1993.
47. Seino KI, Kayagaki N, Okumura K, Yagita H: Antitumor effect of locally produced CD95 ligand Nature Med 3: 165-172, 1997.
48. Strand S, Hofmann WJ, Hug H, Muller GO, Strand D, Mariani SM, Stremmel W, Krammer PH, Galle PF: Lymphocyte apoptosis induced by CDVS (APO-1/Fas) ligand-expressing tumor cells-A mechanism of immune evasion? Nature Med 2: 1361-1366, 1996.
49. Uslu R, Jewett A, Bonavida B: Sensitization of human ovarian tumor cells by subtopic CDDP to anti-Fas antibody-mediated cytotoxicity and apoptosis. Gynecol Oncol 62: 282-291, 1996.
50. Koretz RL: Malignant polyps: are they sheep in wolves'clothing? Ann Int Med 118: 63-68, 1993.
51. Rubio CA: Apoptotic differences in experimentally induced colorectal rat tumors. Apoptosis 3: 35-39, 1998.